JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Year-over-year net income growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -53.53% |
| Q3 2025 | 16.91% |
| Q2 2025 | -33.01% |
| Q1 2025 | 52.23% |
| Q4 2024 | -1.85% |
| Q3 2024 | -78.68% |
| Q2 2024 | 922.70% |
| Q1 2024 | -187.72% |
| Q4 2023 | 6.88% |
| Q3 2023 | 876.56% |
| Q2 2023 | 106.54% |
| Q1 2023 | -524.51% |
| Q4 2022 | -385.43% |
| Q3 2022 | -88.33% |
| Q2 2022 | -21.00% |
| Q1 2022 | 16.78% |
| Q4 2021 | -64.30% |
| Q3 2021 | -11.04% |
| Q2 2021 | -24.94% |
| Q1 2021 | -30.98% |
| Q4 2020 | 38.34% |
| Q3 2020 | 154.55% |
| Q2 2020 | -66.21% |
| Q1 2020 | 28.08% |
| Q4 2019 | -18.45% |
| Q3 2019 | 34.82% |
| Q2 2019 | 286.30% |
| Q1 2019 | -138.07% |
| Q4 2018 | 23.97% |
| Q3 2018 | 3.91% |
| Q2 2018 | 30.76% |
| Q1 2018 | -27.14% |
| Q4 2017 | 65.71% |
| Q3 2017 | -12.83% |
| Q2 2017 | -1.58% |
| Q1 2017 | 24.81% |
| Q4 2016 | -17.26% |
| Q3 2016 | -10.41% |
| Q2 2016 | 420.94% |
| Q1 2016 | -73.47% |